Medxa Pharma Private Limited
About Medxa Pharma Private Limited
Data last updated:
Medxa Pharma Private Limited is a private limited company based in Bardez, Goa, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U24290GA2020PTC014544. Its GSTIN is 30AANCM9455D1ZF (Goa).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pankaj Mahajan and Najib Mohammed Ruknuddin.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 69/1 Mushir Waddo Colvale, Bardez, Goa, India – 403502.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.13 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹23,360 (net margin 0.5%) and EBITDA of ₹43,250 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 209% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No. 69/1 Mushir Waddo Colvale, Bardez, Goa, India – 403502
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medxa Pharma Private Limited
The main business activity of Medxa Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medxa Pharma Private Limited FY 2025 filings available
Medxa Pharma Private Limited reported revenue of ₹43.13 Lakh (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medxa Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 209% over three years, including 16% growth in the latest year. EBITDA rose 987% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medxa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹43,250 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹23,360 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medxa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medxa Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medxa Pharma Private Limited
Medxa Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RTN Pharma Private Limited | ₹43.18 Lakh (FY 2022) | •••• | •••• | 697.0% | •••• | Hosur, Tamil Nadu, India |
| N2n Ingredients Private Limited | ₹43.17 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Tripunithura, Kerala, India |
| Vajire Ishwar Farmer Producer Company Limited | ₹43.16 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Nanded, Maharashtra, India |
| Medicon Ophthalmics Private Limited | ₹43.15 Lakh (FY 2021) | •••• | •••• | -36.0% | •••• | New Delhi, Delhi, India |
| Fashpert Online Services Private Limited | ₹43.13 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Meerut, Uttar Pradesh, India |
| Medxa Pharma Private Limited this company | ₹43.13 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | Bardez, Goa, India |
| Krish Indigenous Technical Equipment Private Limited | ₹43.12 Lakh (FY 2021) | •••• | •••• | -89.0% | •••• | Bhubaneswar, Odisha, India |
| Bizchef Ventures Private Limited | ₹43.12 Lakh (FY 2024) | •••• | •••• | 106.0% | •••• | Bangalore, Karnataka, India |
| Vinu Exports (India) Private Limited | ₹43.12 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Delhi, India |
| Bienoll Petroleum Private Limited | ₹43.12 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | Kozhikode, Kerala, India |
| Medistream Biotech Private Limited | ₹43.12 Lakh (FY 2025) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Medxa Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Medxa Pharma Private Limited
Medxa Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Mahajan | Director | 23 Oct 2020 | 5 Years 11 Months | Current |
| Najib Mohammed Ruknuddin | Director | 23 Oct 2020 | 5 Years 11 Months | Current |
Ownership and Shareholding of Medxa Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medxa Pharma Private Limited
Medxa Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Medxa Pharma Private Limited
Medxa Pharma Private Limited has a workforce of 0 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medxa Pharma Private Limited
Medxa Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Najib Mohammed Ruknuddin was appointed as Director on 23 Oct 2020.
Credit Ratings, Litigation & Regulatory Alerts for Medxa Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medxa Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medxa Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medxa Pharma Private Limited
Medxa Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AANCM9455D1ZF | Goa | Active | 25 Nov 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medxa Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medxa Pharma Private Limited
Medxa Pharma is an active private limited company based in Bardez, Goa, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 October 2020 (6+ years old) and is registered under CIN U24290GA2020PTC014544.
Medxa Pharma reported revenue of ₹43.13 Lakh for FY 2025 (up 16% YoY).
Medxa Pharma has 2 current directors:
- Pankaj Mahajan - Director
- Najib Mohammed Ruknuddin - Director
Medxa Pharma reported a net profit of ₹23,360 (net margin 0.5%) and EBITDA of ₹43,250 (EBITDA margin 1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medxa Pharma is 209% over three years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medxa Pharma is 30AANCM9455D1ZF, registered in Goa.
The CIN (Corporate Identification Number) of Medxa Pharma is U24290GA2020PTC014544. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medxa Pharma was incorporated on 23 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Goa.
The peers of Medxa Pharma by revenue are RTN Pharma Private Limited, N2n Ingredients Private Limited, Vajire Ishwar Farmer Producer Company Limited, Medicon Ophthalmics Private Limited, Fashpert Online Services Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Najib Mohammed Ruknuddin was appointed as Director on 23 Oct 2020. Pankaj Mahajan was appointed as Director on 23 Oct 2020.
The registered office of Medxa Pharma is at H.No. 691 Mushir Waddo Colvale, Bardez, Goa, India – 403502.